Schonfeld Strategic Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-79,464
| Closed | -$1.18M | – | 2375 |
|
|
2025
Q1 | $1.18M | Buy |
79,464
+14,113
| +22% | +$210K | 0.01% | 1107 |
|
|
2024
Q4 | $865K | Sell |
65,351
-17,851
| -21% | -$236K | 0.01% | 1119 |
|
|
2024
Q3 | $1.18M | Sell |
83,202
-6,198
| -7% | -$88.1K | 0.01% | 979 |
|
|
2024
Q2 | $1.16M | Buy |
+89,400
| New | +$1.16M | 0.01% | 1016 |
|
|
2023
Q4 | – | Sell |
-136,100
| Closed | -$2.11M | – | 2041 |
|
|
2023
Q3 | $2.11M | Buy |
+136,100
| New | +$2.11M | 0.02% | 703 |
|
|
2022
Q3 | – | Sell |
-52,700
| Closed | -$740K | – | 3046 |
|
|
2022
Q2 | $740K | Buy |
52,700
+29,100
| +123% | +$409K | 0.01% | 1085 |
|
|
2022
Q1 | $338K | Sell |
23,600
-9,600
| -29% | -$137K | ﹤0.01% | 1553 |
|
|
2021
Q4 | $452K | Buy |
+33,200
| New | +$452K | ﹤0.01% | 1247 |
|
|
2021
Q3 | – | Sell |
-173,500
| Closed | -$2.92M | – | 2298 |
|
|
2021
Q2 | $2.92M | Buy |
173,500
+122,800
| +242% | +$2.07M | 0.03% | 572 |
|
|
2021
Q1 | $926K | Buy |
+50,700
| New | +$926K | 0.01% | 895 |
|
|
2020
Q3 | – | Sell |
-188,764
| Closed | -$3.38M | – | 1591 |
|
|
2020
Q2 | $3.38M | Buy |
+188,764
| New | +$3.38M | 0.09% | 269 |
|
|
2019
Q3 | – | Sell |
-54,900
| Closed | -$971K | – | 1215 |
|
|
2019
Q2 | $971K | Hold |
54,900
| – | – | 0.03% | 449 |
|
|
2019
Q1 | $1.12M | Buy |
+54,900
| New | +$1.12M | 0.04% | 475 |
|